Issue 75, 2020

Chemical modification of ovatodiolide revealed a promising amino-prodrug with improved pharmacokinetic profile

Abstract

Stepwise modification of ovatodiolide revealed a prodrug, NMP-diepoxyovatodiolide, which can provide sustained release of an active compound, substantial metabolic stability and a unique accumulation profile in the liver. Besides, NMP-diepoxyovatodiolide demonstrated therapeutic benefits in an acute autoimmune hepatitis mouse model and a broad safety window. Therefore, NMP-diepoxyovatodiolide is a very promising candidate for further development of liver-related drugs.

Graphical abstract: Chemical modification of ovatodiolide revealed a promising amino-prodrug with improved pharmacokinetic profile

Supplementary files

Article information

Article type
Communication
Submitted
27 Sep 2019
Accepted
19 Aug 2020
First published
20 Aug 2020

Chem. Commun., 2020,56, 11018-11021

Chemical modification of ovatodiolide revealed a promising amino-prodrug with improved pharmacokinetic profile

J. Xiang, X. Zhang, D. Wang, J. Li, Q. Li, Q. Wang, Y. Ding, T. Chen, Y. Sun, S. Bao, J. Chen, D. Li, L. Wang and Y. Chen, Chem. Commun., 2020, 56, 11018 DOI: 10.1039/C9CC07573A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements